Wednesday

8th Dec 2021

Something 'rotten' in EU pharmaceutical sector, says Kroes

  • The commission report points to widespread collusion between European drug makers (Photo: www.freeimages.co.uk)

European competition commissioner Neelie Kroes turned to Shakespeare on Wednesday (8 July) to describe anti-competition practices being widely used by pharmaceutical companies throughout the European union.

"Overall it is indeed a conclusion that there is something rotten in the state," she said, paraphrasing comments made by the character Marcellus in Act I of the British playwright's famous work, Hamlet.

Read and decide

Join EUobserver today

Become an expert on Europe

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

Ms Kroes made the statement following the publication of a final inquiry report on Europe's pharmaceutical sector – a document that points to widespread collusion between drug companies producing original products and others producing generic copies.

According to the report, a considerable number of generic drug producers have accepted payments to delay the release of medicines that are on average 40 percent cheaper than the original product two years after its initial release.

Sending a clear signal that it means to crack down on the practice that results in European citizens paying more for their medicines, the commission has opened a formal antitrust investigation against French company Les Laboratoires Servier and a number of generic drug producers suspected of collusion.

"When it comes to generic entry, every week and month of delay costs money to patients and taxpayers. We will not hesitate to apply the antitrust rules where such delays result from anticompetitive practices," said Ms Kroes.

The case, the first of its kind, surrounds the production of a generic form of perindopril, a cardiovascular medicine used to prevent heart disease and lower blood pressure originally developed by Servier.

The commission says it has evidence of a least a further 200 incidences of illegal agreements between European drug companies, all of which could lead to fines if sufficient evidence is found.

"We hoped to get out a case that is really damaging," said Ms Kroes when asked why the commission had concentrated its first case on Servier and not on other suspected companies, some of which are considerably bigger.

The debate over artificially inflated drug prices is particularly relevant at present as Europe's population grows older and the prospects for both private and public pensions look shakier due to the financial crisis.

"With the ageing population we are going to need more medicine," said Ms Kroes.

European citizens currently spend €214 billion per year on pharmaceuticals, equivalent to 2 percent of the bloc's total GDP or €430 per year per citizen.

The commission report also calls on member states to introduce legislation to facilitate the uptake of generic drugs and says a community patent and specialised patent litigation system in Europe is now more necessary than ever.

At present 30 percent of patent court cases are conducted in parallel in several member states, and in 11 percent of cases national courts reach conflicting judgements.

Opinion

Why are our medicines so expensive?

The EU should be promoting open innovation in upcoming trade talks with India and should work to bring down the prices of essential medicines, both abroad and within its borders.

Denmark and Hungary oppose EU rules on minimum wages

Work ministers reached a common position over EU draft law on minimum wages in Europe, without the support of Denmark and Hungary. The agreement comes after months of negotiations - and strong opposition led by Scandinavian countries.

Slovenian corruption estimated at 13.5% of GDP

Slovenia's anti-corruption commissioner Robert Šumi said the country misses out on €3.5bn a year due to corruption, while the EU chief corruption prosecutor Laura Kövesi visited the country.

Opinion

Using Istanbul Convention to stop online abuse of women

Although legal instruments have been developed, no universally-agreed definition of gender-based violence against women online or via technology exists - and this Council of Europe recommendation aims to fill that gap.

News in Brief

  1. EU agrees to sanction Russian mercenaries
  2. Germany asks Iran for realistic nuclear proposals
  3. US to send troops to Europe if Russia invades Ukraine
  4. Will EU follow US on China Olympics boycott?
  5. EU flight passengers dropped 73% in 2020
  6. EU 'biggest vaccine-donor in world', von der Leyen announces
  7. Majority of EU citizens worried about internet's impact
  8. Redesigned euro banknotes coming from 2024

Latest News

  1. Denmark and Hungary oppose EU rules on minimum wages
  2. Slovenian corruption estimated at 13.5% of GDP
  3. Lithuania seeks EU protection from Chinese bullying
  4. Using Istanbul Convention to stop online abuse of women
  5. EU spends record €198bn on defence in 2020
  6. EU Parliament demands justice after 'anti-vax' attack on MEP
  7. Kaczyński and Le Pen make friends at anti-EU 'summit'
  8. Croat police kept handwritten logbook of likely pushbacks

Join EUobserver

Support quality EU news

Join us